Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC announced the first patient has been dosed in GATHER2, the second Phase 3 clinical trial for Zimura in patients with GA secondary to AMD.
Iveric Bio: Pick Up Post-Fundraising Low And Hold For Good News
12:29pm, Thursday, 25'th Jun 2020
Iveric Bio's stock surged 78% last week to reach $6.65 on positive data from an 18-month trial of its C5 inhibitor Zimura in patients with Geographic Atrophy. T
Two Sigma Investments LP Invests $675,000 in IVERIC bio Inc (NASDAQ:ISEE)
07:38am, Thursday, 25'th Jun 2020
Two Sigma Investments LP bought a new position in shares of IVERIC bio Inc (NASDAQ:ISEE) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The
822,050 Shares in IVERIC bio Inc (NASDAQ:ISEE) Acquired by Deutsche Bank AG
06:46am, Wednesday, 24'th Jun 2020
Deutsche Bank AG purchased a new position in shares of IVERIC bio Inc (NASDAQ:ISEE) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Comm
IVERIC bio, Inc. Announces Closing of Public Offering and Concurrent Private Placement with $160 Million in Gross Proceeds
09:16pm, Monday, 22'nd Jun 2020
IVERIC bio, Inc. announced the closing of public offering and concurrent private placement with $160 million in gross proceeds.
IVERIC bio Inc (NASDAQ:ISEE) Receives Consensus Rating of “Hold” from Analysts
01:46am, Friday, 19'th Jun 2020
Shares of IVERIC bio Inc (NASDAQ:ISEE) have been given a consensus recommendation of “Hold” by the six ratings firms that are currently covering the company, Marketbeat.com reports. Four equities
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
04:50am, Thursday, 18'th Jun 2020
IVERIC bio, Inc. announced the pricing of an upsized underwritten public offering
IVERIC bio, Inc. Announces Proposed Offering of Common Stock and Pre-Funded Warrants and Concurrent Private Placement
08:01pm, Wednesday, 17'th Jun 2020
IVERIC bio today announced that it is commencing an underwritten public offering of $50.0 million of shares of its common stock.
Specsavers stores have reopened for eye tests across Cambridgeshire
04:24pm, Wednesday, 17'th Jun 2020
Specsavers has also introduced a new in-store role to reassure customers who may feel apprehensive about visiting the opticians
Specsavers: England stores open for routine eye tests from today - what to expect
02:00pm, Wednesday, 17'th Jun 2020
SPECSAVERS has opened its doors in England from today for routine eye and hearing testing. What services is it offering and what will the experience look like?
Cowen & Co. Maintains a Buy Rating on IVERIC bio (ISEE) - Markets
12:47pm, Wednesday, 17'th Jun 2020
Cowen & Co. analyst Ken Cacciatore maintained a Buy rating on IVERIC bio (ISEE – Research Report) on June 15
